Home › Funds › D. E. Shaw & Co › LFST
D. E. Shaw & Co position in LFST
LIFESTANCE HEALTH GROUP INC · Health Care
Latest position (Q2 2026)551.83K sh
Reported value held$5.91M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 148.64K | $1.50M | New |
| Q2 2022 | 27.79K | $154.00K | Reduce |
| Q4 2024 | 61.25K | $451.39K | New |
| Q1 2025 | 452.93K | $3.02M | Add |
| Q2 2025 | 330.53K | $1.71M | Reduce |
| Q3 2025 | 15.09K | $83.01K | Reduce |
| Q4 2025 | 138.95K | $978.22K | Add |
| Q1 2026 | 644.15K | $4.10M | Add |
| Q2 2026 | 551.83K | $5.91M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LFST
- Fidelity Management & Research (FMR) 58.25M sh · $623.88M · Q2 2026
- BlackRock Inc 36.35M sh · $389.29M · Q2 2026
- Vanguard Group 17.70M sh · $124.61M · Q4 2025
- Geode Capital Management 5.59M sh · $59.91M · Q2 2026
- Morgan Stanley 5.02M sh · $53.78M · Q2 2026
- Principal Global Investors 4.00M sh · $42.81M · Q2 2026
- Millennium Management 3.61M sh · $38.63M · Q2 2026
- Wellington Management Group 2.88M sh · $30.88M · Q2 2026
- Northern Trust Corp 2.14M sh · $22.90M · Q2 2026
- Charles Schwab Investment Management 1.98M sh · $21.20M · Q2 2026
- Goldman Sachs Group 1.81M sh · $19.40M · Q2 2026
- Marshall Wace 1.63M sh · $17.43M · Q2 2026